222 related articles for article (PubMed ID: 31174055)
1. Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial.
Alexandre J; Ollitrault P; Fischer MO; Fellahi JL; Rozec B; Cholley B; Dolladille C; Chequel M; Allouche S; Legallois D; Saplacan V; Buklas D; Beygui F; Parienti JJ; Milliez P
Am Heart J; 2019 Aug; 214():88-96. PubMed ID: 31174055
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of aldosterone antagonists for preventing atrial fibrillation after cardiac surgery in patients with systolic heart failure: a retrospective study.
Simopoulos V; Tagarakis G; Hatziefthimiou A; Skoularigis I; Triposkiadis F; Trantou V; Tsilimingas N; Aidonidis I
Clin Res Cardiol; 2015 Jan; 104(1):31-7. PubMed ID: 25134923
[TBL] [Abstract][Full Text] [Related]
3. A propensity-score matched analysis on the impact of postoperative atrial fibrillation on the early and late outcomes after concomitant aortic valve replacement and coronary artery bypass graft surgery.
Saxena A; Shi WY; Paramanathan A; Herle P; Dinh D; Smith JA; Reid CM; Shardey G; Newcomb AE
J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):199-206. PubMed ID: 24572338
[TBL] [Abstract][Full Text] [Related]
4. Short-course of ranolazine prevents postoperative atrial fibrillation following coronary artery bypass grafting and valve surgeries.
Hammond DA; Smotherman C; Jankowski CA; Tan S; Osian O; Kraemer D; DeLosSantos M
Clin Res Cardiol; 2015 May; 104(5):410-7. PubMed ID: 25416563
[TBL] [Abstract][Full Text] [Related]
5. Atrial fibrillation following aortic valve replacement: impact of perioperative use of intravenous β-blocker.
Yokota J; Nishi H; Sekiya N; Yamada M; Takahashi T
Gen Thorac Cardiovasc Surg; 2017 Apr; 65(4):194-199. PubMed ID: 28000150
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation after cardiac surgery: a major morbid event?
Almassi GH; Schowalter T; Nicolosi AC; Aggarwal A; Moritz TE; Henderson WG; Tarazi R; Shroyer AL; Sethi GK; Grover FL; Hammermeister KE
Ann Surg; 1997 Oct; 226(4):501-11; discussion 511-3. PubMed ID: 9351718
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Spironolactone on Acute Kidney Injury After Cardiac Surgery: A Randomized, Placebo-Controlled Trial.
Barba-Navarro R; Tapia-Silva M; Garza-Garcia C; López-Giacoman S; Melgoza-Toral I; Vázquez-Rangel A; Bazúa-Valenti S; Bobadilla N; Wasung de Lay M; Baranda F; Chawla LS; Gamba G; Madero M
Am J Kidney Dis; 2017 Feb; 69(2):192-199. PubMed ID: 27522513
[TBL] [Abstract][Full Text] [Related]
8. The effect of intravenous N-acetylcysteine on prevention of atrial fibrillation after coronary artery bypass graft surgery: a double-blind, randomised, placebo-controlled trial.
Soleimani A; Habibi MR; Hasanzadeh Kiabi F; Alipour A; Habibi V; Azizi S; Emami Zeydi A; Sohrabi FB
Kardiol Pol; 2018; 76(1):99-106. PubMed ID: 28980294
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation.
Piccini JP; Ahlsson A; Dorian P; Gillinov AM; Kowey PR; Mack MJ; Milano CA; Noiseux N; Perrault LP; Ryan W; Steinberg JS; Voisine P; Waldron NH; Gleason KJ; Titanji W; Leaback RD; O'Sullivan A; Ferguson WG; Benussi S;
JACC Clin Electrophysiol; 2024 May; 10(5):930-940. PubMed ID: 38661602
[TBL] [Abstract][Full Text] [Related]
10. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
Gersak B; Sutlic Z
Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.
Mooss AN; Wurdeman RL; Sugimoto JT; Packard KA; Hilleman DE; Lenz TL; Rovang KS; Arcidi JM; Mohiuddin SM
Am Heart J; 2004 Oct; 148(4):641-8. PubMed ID: 15459595
[TBL] [Abstract][Full Text] [Related]
12. Preoperative plasma aldosterone and the risk of atrial fibrillation after coronary artery bypass surgery: a prospective cohort study.
Alexandre J; Saloux E; Chequel M; Allouche S; Ollitrault P; Plane AF; Legallois D; Fischer MO; Saplacan V; Buklas D; Labombarda F; Blanchart K; Salem JE; Nowoczyn M; Puddu PE; Manrique A; Parienti JJ; Milliez P
J Hypertens; 2016 Dec; 34(12):2449-2457. PubMed ID: 27584972
[TBL] [Abstract][Full Text] [Related]
13. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study.
Gomes JA; Ip J; Santoni-Rugiu F; Mehta D; Ergin A; Lansman S; Pe E; Newhouse TT; Chao S
J Am Coll Cardiol; 1999 Aug; 34(2):334-9. PubMed ID: 10440141
[TBL] [Abstract][Full Text] [Related]
14. Partial CArdiac Denervation to Prevent Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting (pCAD-POAF): Study Protocol for a Randomized Controlled Trial.
Yang Z; Tiemuerniyazi X; Huang S; Song Y; Xu F; Feng W
Am J Cardiol; 2024 Jun; 221():120-125. PubMed ID: 38649126
[TBL] [Abstract][Full Text] [Related]
15. Predictors of post-operative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting.
Gorczyca I; Michta K; Pietrzyk E; Wożakowska-Kapłon B
Kardiol Pol; 2018; 76(1):195-201. PubMed ID: 29168552
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction.
Desai AS; Lewis EF; Li R; Solomon SD; Assmann SF; Boineau R; Clausell N; Diaz R; Fleg JL; Gordeev I; McKinlay S; O'Meara E; Shaburishvili T; Pitt B; Pfeffer MA
Am Heart J; 2011 Dec; 162(6):966-972.e10. PubMed ID: 22137068
[TBL] [Abstract][Full Text] [Related]
17. IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial.
Shantsila E; Haynes R; Calvert M; Fisher J; Kirchhof P; Gill PS; Lip GY
BMJ Open; 2016 Oct; 6(10):e012241. PubMed ID: 27707827
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing postoperative atrial fibrillation in patients undergoing on-pump coronary artery bypass grafting, single center experience.
Ismail MF; El-Mahrouk AF; Hamouda TH; Radwan H; Haneef A; Jamjoom AA
J Cardiothorac Surg; 2017 May; 12(1):40. PubMed ID: 28535775
[TBL] [Abstract][Full Text] [Related]
19. The changing face of postoperative atrial fibrillation prevention: a review of current medical therapy.
Mayson SE; Greenspon AJ; Adams S; Decaro MV; Sheth M; Weitz HH; Whellan DJ
Cardiol Rev; 2007; 15(5):231-41. PubMed ID: 17700382
[TBL] [Abstract][Full Text] [Related]
20. Effects of Spironolactone on Hypoxia-Inducible Factor-1α in the Patients Receiving Coronary Artery Bypass Grafting.
Lou YM; Zheng ZL; Xie LY; Lian JF; Shen WJ; Zhou JQ; Shao GF; Hu DX
J Cardiovasc Pharmacol; 2021 Jul; 78(1):e101-e104. PubMed ID: 34173801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
